Patterns of Aneusomy for Three Chromosomes in Individual Cells from Breast Cancer Tumors

Keywords

Malignancy, Breast cancer, Biology, Breast carcinoma, Pathology

References

• Chromosome-specific aneusomy in carcinoma of the breast.Diane L. Persons, Robert A. Robinson, Ping H. Hsu — 1996
• Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.Marc S. Greenblatt, W P Bennett, Monica Hollstein — 1994
• Incidence of chromosomes 1 and 17 aneusomy in breast cancer and adjacent tissue: an interphase cytogenetic study.Claudio Botti, B Pescatore, Marcella Mottolese — 2000
• Comparative genomic hybridization of formalin-fixed, paraffin-embedded breast tumors reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas.Thomas Ried, K E Just, Heidi Holtgreve-Grez — 1995
• Interphase cytogenetics in mammographically detected breast lesions.Nour Sneige, Ayşegül Şahin, Mai Dinh — 1996
• Detection of chromosomal aneusomy by fluorescence in situ hybridization in fine‐needle aspirates from breast tumorsFumine Tsukamoto, Yasuo Miyoshi, Hiroki Koyama — 2000
• Interphase fluorescence in situ hybridization improves the detection of malignant cells in effusions from breast cancer patients.Niklas Zojer, Michael Fiegl, J Angerler — 1997
• Genetic alterations of chromosome 17 in human breast carcinoma studied by fluorescence in situ hybridization and molecular DNA techniques.Carla Rosenberg, Tone Ikdahl Andersen, Jahn M. Nesland — 1994
• Identification and characterization of circulating prostate carcinoma cellsZhengpin Wang, Mario A. Eisenberger, Michael A. Carducci — 2000
• Clone heterogeneity in diploid and aneuploid breast carcinomas as detected by FISH.Fulvia Farabegoli, Donatella Santini, Claudio Ceccarelli — 2001
• Chromosome abnormalities in breast fibroadenomas.Yavuz Özışık, Aurelia M. Meloni, Christine F. Stephenson — 1994
• Stage I and stage II infiltrating ductal carcinoma of the breast analyzed for chromosome 8 copy number using fluorescent in situ hybridization.Hon Fong L. Mark, William Taylor, Alaa Afify — 1997
• Clinicopathologic analysis of breast carcinoma with chromosomal aneusomy detected by fluorescence in situ hybridizationFumine Tsukamoto, Yasuo Miyoshi, Chiyomi Egawa — 2001
• Genetic alterations in breast cancerIvan Bièche, Rosette Lidereau — 1995
• Interphase cytogenetics reveals a high incidence of aneuploidy and intra-tumour heterogeneity in breast cancer.Michael Fiegl, C Tueni, Thomas Schenk — 1995
• Aneuploidy of chromosome 8 as detected by interphase fluorescence in situ hybridization is a recurrent finding in primary and metastatic breast cancerR. Roka, Michael Fiegl, Niklas Zojer — 1998
• Analysis of numerical aberrations in specific chromosomes by fluorescent in situ hybridization as a diagnostic tool in breast cancerDaisuke Ichikawa, Naoya Hashimoto, Masakazu Hoshima — 1996
• Somatic genetic changes in human breast cancer.Peter Devilee — 1994
• Interphase cytogenetics: Analysis of numerical chromosome aberrations in isolated cellsC. Simon Herrington, Kylie Cooper, J O McGee — 1995
• Advantages and limitations of using fluorescence in situ hybridization for the detection of aneuploidy in interphase human cells.David A. Eastmond, Maik Schuler, D.S. Rupa — 1995

Cited by

• Malignant characteristics of circulating tumor cells and corresponding primary tumor in a patient with esophageal squamous cell carcinoma before and after surgeryÓscar Ferrer Fuertes — 2011
• Vergleich einer neuen RT-PCR-basierten Methode zum Nachweis disseminierter Tumorzellen im Knochenmark von Mammakarzinompatientinnen mit ImmunzytochemieMałgorzata Banyś — 2010
• Prediction of Axillary Lymph Node Status of Breast Cancer Patients by Tumorbiological Factors of the Primary TumorTanja Fehm, Holger Maul, Sigrun Gebauer — 2005
• Ductal approaches to assessment and management of women at high risk for developing breast cancerImogen Locke, Gillian Mitchell, Rosalind A. Eeles — 2004
• Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant.Tanja Fehm, Arthur I. Sagalowsky, Edward Clifford — 2002
• High expression of focal adhesion kinase (p125FAK) in node-negative breast cancer is related to overexpression of HER-2/neu and activated Akt kinase but does not predict outcomeKlaus J. Schmitz, Florian Grabellus, R. Callies — 2005
• Determinación de anomalías cromosómicas y secuencias de ADN amplificadas en cáncer de mamaMilena Rondón L., José Caicedo M., José Fernando Robledo — 2006
• [Detection of disseminated tumor cells in the bone marrow of breast cancer patients with a new molecular method].M. Banyś, N. Krawczyk, S. Becker — 2012
• c-myc, not her-2/neu, can predict the prognosis of breast cancer patients: how novel, how accurate, and how significant?Fernando Schmitt, Jorge S. Reis‐Filho — 2003
• Human BRCA1-Associated Breast Cancer: No Increase in Numerical Chromosomal Instability Compared to Sporadic TumorsTim Focken, D. Steinemann, Britta Skawran — 2011
• Nanotopographic Biomaterials for Isolation of Circulating Tumor CellsWeiyi Qian, Yan Zhang, Andrew H. Gordon — 2014
• Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapiesMitra Tewes, Bahriye Aktas, Anja Welt — 2009
• Slit Protein-mediated Inhibition of CXCR4-induced Chemotactic and Chemoinvasive Signaling Pathways in Breast Cancer Cells*Anil Prasad, Aaron Z. Fernandis, Yi Rao — 2004
• Methods for isolating circulating epithelial cells and criteria for their classification as carcinoma cells.Tanja Fehm, Erich‐Franz Solomayer, Songdong Meng — 2005
• Breast cancer and aneusomy 17: implications for carcinogenesis and therapeutic responseMonica M. Reinholz, Amy K. Bruzek, Daniel W. Visscher — 2009
• Correlation of cytologic findings and chromosomal instability detected by fluorescence in situ hybridization in breast fine-needle aspiration specimens from women at high risk for breast cancerNour Sneige, Baoshun Liu, Guosheng Yin — 2006
• uPAR and HER2 Genes Are Usually Co-Amplified in Individual Breast Cancer Cells from Blood and TissuesJonathan W. Uhr — 2008
• Prognostic Value of TOP2A Gene Amplification and Chromosome 17 Polysomy in Early Breast CancerAnna J. Żaczek, Aleksandra Markiewicz, Anna Supernat — 2012
• Changes in the Expression of Many Ets Family Transcription Factors and of Potential Target Genes in Normal Mammary Tissue and Tumors*Christina K. Galang, William J. Muller, Gabriele Foos — 2004
• Clinical relevance of circulating CK-19 mRNA-positive cells detected during the adjuvant tamoxifen treatment in patients with early breast cancer.N. Xenidis, V. Markos, Stella Apostolaki — 2007

Related papers

• Utility of CT-guided biopsy of suspicious skeletal lesions in patients with known primary malignancies.Glen A. Toomayan, Nancy M. Major — 2011
• Evaluating the risk of underlying malignancy in patients with pathologic nipple dischargeGeorge Z. Li, Stephanie M. Wong, Susan C. Lester — 2018
• Malignancy in non-HIV infected patients with cryptococcal meningitis: a retrospective studyXiaofeng Xu, Liping Cao, Yijie Wang — 2020
• A study on the relationship between malignancy and diabetes.Sebiha Ozge Duman, Merve Kayali Sevim, Nevin Dınççağ — 2023
• Expression and localization of LAT1 and 4F2hc in lactation mammary gland of dairy cowTianying Huang — 2013
• Malignancy in non-HIV infected patients with cryptococcal meningitis: a retrospective studyXiaofeng Xu, Liping Cao, Yijie Wang — 2020
• Rate of Malignancy in the Complex Renal Cystic Lesions (Bosniak Iif, Iii, Iv) Single Center StudySyed Rafi Uddin Shah, Jamal Muustafa Khan, Hafiz Dur E Furqani — 2022
• Analysis of lymphocytes from uranium mineworkers in Namibia for chromosomal damage using fluorescence in situ hybridization (FISH)Reinhard Zaire, C.S. Griffin, Paul J. Simpson — 1997